Acute kidney injury in cancer patients and impedance cardiography‑assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital

Wang,Tao; Zhang,Yan; Li,Qingxia; Jia,Shumin; Shi,Changjin; Niu,Kai; Liu,Bing

doi:10.3892/etm.2017.5244

Acute kidney injury in cancer patients and impedance cardiography‑assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital

Authors:
- Tao Wang
- Yan Zhang
- Qingxia Li
- Shumin Jia
- Changjin Shi
- Kai Niu
- Bing Liu
View Affiliations

Affiliations: Department of Nephrology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Department of Dermatology, Hebei Provincial Tumor Hospital, Shijiazhuang, Hebei 050011, P.R. China, Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Hemodialysis Center, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Department of Urology, Hebei Provincial Tumor Hospital, Shijiazhuang, Hebei 050011, P.R. China
Published online on: October 2, 2017 https://doi.org/10.3892/etm.2017.5244
Pages: 5671-5677

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute kidney injury (AKI) in cancer patients may disrupt anticarcinogenic treatment and greatly increase associated mortality rates. The present study reported on the management of cancer patients with AKI and, from the nephrologic viewpoint, on the significance of fine volume control during the continuous renal replacement therapy (CRRT). The records of 117 cancer patients with AKI treated over three years were reviewed and their data were compared with those of 120 healthy controls. AKI was defined according to the Kidney Disease: Improving Global Outcomes criteria with serum creatinine levels determined on initial admission and for the diagnosis of AKI. CRRT with concomitant impedance cardiography (ICG) monitoring was performed in 79 patients. On average, AKI manifested as a 1.68±0.38‑fold increase in serum creatinine within 10.2±5.7 days. The causes of AKI were diverse, with the major ones being nephrotoxic agents, hypotension and obstructive nephropathy. Renal biopsy confirmed two cases of thrombotic microangiopathy, due to the use of interfon‑α and sunitinib malate, respectively, and a third case of cast nephropathy caused by immunoglobulin D multiple myeloma. The patients were generally marantic and had compromised cardiac function compared with the healthy controls. The CRRT prescription was discriminatingly optimized by the ICG parameters effecting discreet fluid balance, as the thoracic fluid content was significantly correlated with the ultrafiltration rate. By considering the causative mechanisms and applying subtle ICG‑assisted volume control, the present study may thus help to improve the safety and efficacy of CRRT in cancer patients with AKI. In addition, it provided information to bring advances in onconephrology, a novel nephrological subspecialty field.

View Figures

View References

1	Lameier NH, Flombaum CD, Moreau D and Ronco C: Acute renal failure in cancer patients. Ann Med. 37:13–25. 2005. View Article : Google Scholar : PubMed/NCBI
2	Finkel KW and Foringer JR: Renal disease in patients with cancer. Nat Clin Pract Nephrol. 3:669–678. 2007. View Article : Google Scholar : PubMed/NCBI
3	Humphreys BD, Soiffer RJ and Magee CC: Renal failure associated with cancer and its treatment: An update. J Am Soc Nephrol. 16:151–161. 2005. View Article : Google Scholar : PubMed/NCBI
4	Perazella MA and Moeckel GW: Nephrotoxicity from chemotherapeutic agents: Clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol. 30:570–581. 2010. View Article : Google Scholar : PubMed/NCBI
5	Wang T, Ma HC, Bai YL, Zhang JX and Xu JS: Continuous venovenous hemodiafiltration, impedance cardiography and critical care nephrology: A case study of chronic myeloid leukemia-associated acute renal failure. Crit Care Shock. 14:19–23. 2011.
6	Yerram P, Karuparthi PR and Misra M: Fluid overload and acute kidney injury. Hemodial Int. 14:348–354. 2010. View Article : Google Scholar : PubMed/NCBI
7	Soares M, Salluh JI, Carvalho MS, Darmon M, Ronco JR and Spector N: Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol. 24:4003–4010. 2006. View Article : Google Scholar : PubMed/NCBI
8	Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA and Decruyenaere JM: Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: Comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant. 20:552–558. 2005. View Article : Google Scholar : PubMed/NCBI
9	Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B and Azoulay E: Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med. 33:765–772. 2007. View Article : Google Scholar : PubMed/NCBI
10	Berghmans T, Meert AP, Markiewicz E and Sculier JP: Continuous venovenous haemofiltration in cancer patients with renal failure: A single-centre experience. Support Care Cancer. 12:306–311. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kazory A and Ross EA: Contemporary trends in the pharmacological and extracorporeal management of heart failure: A nephrologic perspective. Circulation. 117:975–983. 2008. View Article : Google Scholar : PubMed/NCBI
12	Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, et al: Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 47:2245–2252. 2006. View Article : Google Scholar : PubMed/NCBI
13	Salahudeen AK and Bonventre JV: Onconephrology: The latest frontier in the war against kidney disease. J Am Soc Nephrol. 24:26–30. 2013. View Article : Google Scholar : PubMed/NCBI
14	Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2:19–36. 2012.
15	Wang T, Zhang Y, Ma J, Feng Z, Niu K and Liu B: Additive effect of polymorphisms in the β2-adrenoceptor and NADPH oxidase p22 phox genes contributes to the loss of estimated glomerular filtration rate in Chinese. Clin Exp Pharmacol Physiol. 41:657–662. 2014.PubMed/NCBI
16	Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A, Ludwig H, Joshua D, Mehta J, Gertz M, et al: Consensus recommendations for standard investigative workup: Report of the international myeloma workshop consensus panel 3. Blood. 117:4701–4705. 2011. View Article : Google Scholar : PubMed/NCBI
17	Donauer J, Kölblin D, Bek M, Krause A and Böhler J: Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects. Am J Kidney Dis. 36:115–123. 2000. View Article : Google Scholar : PubMed/NCBI
18	Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP and Sørensen HT: Incidence of acute kidney injury in cancer patients: A Danish population-based cohort study. Eur J Intern Med. 22:399–406. 2011. View Article : Google Scholar : PubMed/NCBI
19	Mehta RL, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM and Chertow GM: Nephrology consultation in acute renal failure: Does timing matter? Am J Med. 113:456–461. 2002. View Article : Google Scholar : PubMed/NCBI
20	Thajudeen B and Salahudeen AK: Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: Current data and future perspectives. Cancer Manag Res. 8:105–114. 2016. View Article : Google Scholar : PubMed/NCBI
21	Jaeger JQ and Mehta RL: Assessment of dry weight in hemodialysis: An overview. J Am Soc Nephrol. 10:392–403. 1999.PubMed/NCBI
22	Seo-Mayer P, Kenney B, McNamara J, Stein J and Moeckel GW: Hematuria and decreased kidney function as initial signs of acute B-cell lymphoblastic leukemia. Am J Kidney Dis. 56:1001–1005. 2010. View Article : Google Scholar : PubMed/NCBI
23	Segal A: A case of acute kidney injury due to complex, partial, multifocal ureteral strictures. Nat Clin Pract Nephrol. 4:102–108. 2008. View Article : Google Scholar : PubMed/NCBI
24	Pabla N and Dong Z: Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int. 73:994–1007. 2008. View Article : Google Scholar : PubMed/NCBI
25	Perazella MA: Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol. 4:1275–1283. 2009. View Article : Google Scholar : PubMed/NCBI
26	Miller RP, Tadagavadi RK, Ramesh G and Reeves WB: Mechanisms of cisplatin nephrotoxicity. Toxins (Basel). 2:2490–2518. 2010. View Article : Google Scholar : PubMed/NCBI
27	de Jonge MJ and Verweij J: Renal toxicities of chemotherapy. Semin Oncol. 33:68–73. 2006. View Article : Google Scholar : PubMed/NCBI
28	Badid C, McGregor B, Faivre JM, Guerard A, Juillard L, Fouque D and Laville M: Renal thrombotic microangiography induced by interfon-alpha. Nephrol Dial Transplant. 16:846–848. 2001. View Article : Google Scholar : PubMed/NCBI
29	Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, et al: Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 356:2582–2590. 2007. View Article : Google Scholar : PubMed/NCBI
30	Jancelewicz Z, Takatsuki K, Sugai S and Pruzanski W: IgD multiple myeloma: review of 133 cases. Arch Intern Med. 135:87–93. 1975. View Article : Google Scholar : PubMed/NCBI
31	Shimamoto Y, Anami Y and Yamaguchi M: A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur J Haematol. 47:262–267. 1991. View Article : Google Scholar : PubMed/NCBI
32	Sinclair D and Cranfield T: IgD myeloma: A potential missed diagnosis. Ann Clin Biochem. 38:564–565. 2001. View Article : Google Scholar : PubMed/NCBI